Zcwpw1 — Zinc Finger Cw Type And Pwwp Domain is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
ZCWPW1 (Zinc Finger CW-Type and PWWP Domain Containing 1) encodes a chromatin-binding protein with potential epigenetic regulatory functions. GWAS have identified ZCWPW1 as a susceptibility gene for late-onset Alzheimer's disease (LOAD), suggesting a role for epigenetic regulation in AD pathogenesis.[1]
ZCWPW1 is a 541 amino acid protein containing CW-type and PWWP domains, which are known to bind to modified histones and participate in chromatin remodeling and gene regulation.[2]
Key normal functions include:
ZCWPW1 has been identified as a LOAD risk gene through GWAS meta-analyses. The protective variant is associated with reduced AD risk. The mechanism likely involves epigenetic regulation of genes involved in neurodegeneration.[1][3]
Potential Mechanisms:
ZCWPW1 expression:
The study of Zcwpw1 — Zinc Finger Cw Type And Pwwp Domain has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] ZCWPW1 and Alzheimer disease risk. PMID:24162737
References
[1] Lambert JC, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet. 2013;45(12):1452-1458.
[2] Wu H, et al. Structural basis of histone modifications by CW and PWWP domains. J Mol Biol. 2011;413(5):873-887.
[3] Liu X, et al. Epigenetic mechanisms in Alzheimer's disease. Nat Rev Neurol. 2012;8(8):481-492.
[4] Ben-David E, et al. Genetic and chromatin context in Alzheimer's disease. Nat Rev Neurol. 2016;12(11):645-657.
ZCWPW1 is an emerging therapeutic target for AD. Strategies to modulate ZCWPW1 function could potentially influence epigenetic regulation of AD-related genes. The epigenetic nature of ZCWPW1 makes it a challenging but potentially impactful target.
| Approach | Target | Stage | Indication |
|---|---|---|---|
| Small molecule modulators | ZCWPW1 | Discovery | AD |
| Gene therapy | ZCWPW1 expression | Preclinical | AD |
| Epigenetic therapies | Histone modification | Discovery | AD |
Research on ZCWPW1 focuses on understanding its role in epigenetic regulation in the brain. Studies are investigating how ZCWPW1 variants modify AD risk. Additionally, research is exploring the role of ZCWPW1 in microglial function and neuroinflammation.